BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine
Go back to BrainStorm Cell Therapeutics Announces Publication Calling for Updated FDA Approaches to ALS, Rare Diseases and Regenerative Medicine| Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) | Delayed: 1.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.17 | 52 Week High | $3.87 | |||
| Open | $1.17 | 52 Week Low | $1.90 | |||
| Day High | $1.17 | P/E | N/A | |||
| Day Low | $1.17 | EPS | $-0.03 | |||
| Volume | 11,852 | |||||
